The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BLLN · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | PDEX | TCMD | ENSG | BLLN |
|---|---|---|---|---|
| Moat Score (0–100) | 72 | 73 (highest) | 72 | 72 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 90 | 75 | 95 (highest) | 85 |
| Pricing power | 44 | 100 (highest) | 33 | 59 |
| Returns on capital | 62 | 27 | 74 (highest) | — |
| Balance-sheet safety | 65 | 100 (highest) | 100 (highest) | 100 (highest) |
| Capital allocation | 100 (highest) | 60 | 60 | 44 |
| 161% above value if growth stopped today | 160% above value if growth stopped today (largest discount to value if growth stopped today) | 302% above value if growth stopped today | No price data | |
| Market cap | $179M | $617M | $10.0B | $2.7B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |